Peter Rost, M.D., is a former Pfizer Marketing Vice President providing services as a medical device and drug expert witness and pharmaceutical marketing expert. Judge Sanders: "The court agrees with defendants' view that Dr. Rost is a very adept and seasoned expert witness." He is also the author of Emergency Surgery, The Whistleblower and Killer Drug. You can reach him on rostpeter (insert symbol) hotmail.com. Follow on https://twitter.com/peterrost
Tuesday, September 02, 2008
New England Journal of Medicine: Vytorin/Zetia cancer increase should not be assumed to be a chance finding until further data are in.
"The fact that the combined data from all three trials showed an increase in cancer mortality with ezetimibe [Zetia] should not be assumed to be a chance finding until further data are in. "
No comments:
Post a Comment